JP2013503880A5 - - Google Patents

Download PDF

Info

Publication number
JP2013503880A5
JP2013503880A5 JP2012528002A JP2012528002A JP2013503880A5 JP 2013503880 A5 JP2013503880 A5 JP 2013503880A5 JP 2012528002 A JP2012528002 A JP 2012528002A JP 2012528002 A JP2012528002 A JP 2012528002A JP 2013503880 A5 JP2013503880 A5 JP 2013503880A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
pharmaceutical composition
group
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012528002A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013503880A (ja
JP5653438B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/047488 external-priority patent/WO2011028775A1/en
Publication of JP2013503880A publication Critical patent/JP2013503880A/ja
Publication of JP2013503880A5 publication Critical patent/JP2013503880A5/ja
Application granted granted Critical
Publication of JP5653438B2 publication Critical patent/JP5653438B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012528002A 2009-09-04 2010-09-01 オルトミクソウイルス感染の治療方法 Expired - Fee Related JP5653438B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US27225409P 2009-09-04 2009-09-04
US61/272,254 2009-09-04
US28250810P 2010-02-22 2010-02-22
US61/282,508 2010-02-22
US35393510P 2010-06-11 2010-06-11
US61/353,935 2010-06-11
PCT/US2010/047488 WO2011028775A1 (en) 2009-09-04 2010-09-01 Methods of treating orthomyxoviral infections

Publications (3)

Publication Number Publication Date
JP2013503880A JP2013503880A (ja) 2013-02-04
JP2013503880A5 true JP2013503880A5 (enExample) 2014-03-20
JP5653438B2 JP5653438B2 (ja) 2015-01-14

Family

ID=43649616

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012528002A Expired - Fee Related JP5653438B2 (ja) 2009-09-04 2010-09-01 オルトミクソウイルス感染の治療方法

Country Status (12)

Country Link
US (2) US20110065752A1 (enExample)
EP (1) EP2473482B1 (enExample)
JP (1) JP5653438B2 (enExample)
KR (1) KR101497194B1 (enExample)
CN (1) CN102625796B (enExample)
BR (1) BR112012004676A2 (enExample)
CA (1) CA2772875A1 (enExample)
DK (1) DK2473482T3 (enExample)
ES (1) ES2466027T3 (enExample)
MX (1) MX2012002486A (enExample)
PL (1) PL2473482T3 (enExample)
WO (1) WO2011028775A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2579628T3 (es) 2009-02-23 2016-08-12 Emergent Virology Llc Iminoazúcares y métodos de tratamiento de enfermedades virales
US8921568B2 (en) 2012-06-06 2014-12-30 Unither Virology, Llc Iminosugars and their applications
AP2016009125A0 (en) * 2013-09-16 2016-04-30 Emergent Virology Llc Deoxynojirimycin derivatives and methods of their using
WO2016073652A1 (en) 2014-11-05 2016-05-12 Unither Virology, Llc Iminosugars useful for the treatment of viral diseases
WO2017201030A1 (en) * 2016-05-16 2017-11-23 Emergent Virology Llc Methods of treating viral infection
US20220257604A1 (en) * 2019-03-08 2022-08-18 University Of Virginia Patent Foundation Compositions and methods for modulating viral infections by regulating glucosylceramides
CN111904959A (zh) * 2020-08-21 2020-11-10 牡丹江医学院 α-L-岩藻糖苷酶抑制剂在制备治疗小儿肺炎的药物中的用途
IT202200007808A1 (it) * 2022-04-20 2023-10-20 Luigi Michele Pavone Composizioni terapeutiche per malattie causate da accumulo di eparan solfato
CN119841765B (zh) * 2025-01-09 2025-10-10 中南大学 Dnj衍生物、药物组合物及其应用

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8013A (en) * 1851-04-01 Improvement in wheat-fans
GB1555654A (en) * 1977-06-25 1979-11-14 Exxon Research Engineering Co Agricultural burner apparatus
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
DE2834122A1 (de) * 1978-08-03 1980-02-14 Bayer Ag Verfahren zur herstellung von 6-amino-6-desoxy-l-sorbose
DE2839309A1 (de) * 1978-09-09 1980-03-27 Bayer Ag 3,4,5-trihydroxypiperidin-derivate
DE2853573A1 (de) * 1978-12-12 1980-07-03 Bayer Ag Herstellung von n-substituierten derivaten des l-desoxynojirimycins
DE3038901A1 (de) * 1980-10-15 1982-05-06 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von n-substituierten derivaten des 1-desoxynojirimycins
DE3611841A1 (de) * 1986-04-09 1987-10-15 Bayer Ag Verfahren zur herstellung von 1-desoxynojirimycin und dessen n-derivaten
US5043273A (en) * 1989-08-17 1991-08-27 Monsanto Company Phosphorylated glycosidase inhibitor prodrugs
US5103008A (en) * 1989-08-17 1992-04-07 Monsanto Company Compound, N-butyl-deoxynojirimycin-6-phosphate
US4994572A (en) * 1989-10-12 1991-02-19 Monsanto Company Synthesis of nojirimycin derivatives
US5030638A (en) * 1990-02-26 1991-07-09 G. D. Searle & Co. Method of antiviral enhancement
US5200523A (en) * 1990-10-10 1993-04-06 Monsanto Company Synthesis of nojirimycin derivatives
US5206251A (en) * 1992-04-01 1993-04-27 G. D. Searle & Co. 2- and 3- amino and azido derivatives of 1,5-iminosugars
US5399567A (en) * 1993-05-13 1995-03-21 Monsanto Company Method of treating cholera
AU1876095A (en) * 1994-02-25 1995-09-11 G.D. Searle & Co. Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus
EP1037636A4 (en) * 1997-12-11 2004-08-18 Univ Oxford INHIBITATION OF MEMBRANE-TIED VIRAL REPLICATION
US6689759B1 (en) * 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
US6610703B1 (en) * 1998-12-10 2003-08-26 G.D. Searle & Co. Method for treatment of glycolipid storage diseases
GB9828474D0 (en) * 1998-12-24 1999-02-17 British Aerospace Surface topology inspection
ATE402701T1 (de) * 1999-02-12 2008-08-15 United Therapeutics Corp N-(8,8,8-trifluorooctyl)-1,5-dideoxy-1,5-imino- - glucitol zur behandlung von hepatitis-virus- infektionen
GB0100889D0 (en) * 2001-01-12 2001-02-21 Oxford Glycosciences Uk Ltd Compounds
AU6050600A (en) * 1999-07-26 2001-02-13 G.D. Searle & Co. Use of long-chain n-alkyl derivates of deoxynojirimycin and a glucocerebrosidaseenzyme for the manufacture of medicament for the treatment of glycolipid storag e diseases
HK1046869A1 (zh) * 1999-08-10 2003-01-30 The Chancellor, Masters And Scholars Of The University Of Oxford 使用长链n烷基化合物及其恶衍生物作为抗病毒成分
US7256005B2 (en) * 1999-08-10 2007-08-14 The Chancellor, Masters And Scholars Of The University Of Oxford Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity
EP2444102B1 (en) * 2003-01-31 2015-04-08 The Mount Sinai School of Medicine of New York University Combination therapy for treating protein deficiency disorders
US7446098B2 (en) * 2003-02-18 2008-11-04 Mount Sinai School Of Medicine Of New York University Combination therapy for treating protein deficiencies
US20050256168A1 (en) * 2004-04-28 2005-11-17 Block Timothy M Compositions for oral administration for the treatment of interferon-responsive disorders
US7524829B2 (en) * 2004-11-01 2009-04-28 Avi Biopharma, Inc. Antisense antiviral compounds and methods for treating a filovirus infection
GB0501352D0 (en) * 2005-01-21 2005-03-02 Slingsby Jason H Use of glycosylation modulators in combination with membrane fusion inhibitors for treatment of infections caused by viruses bearing glycosylated envelope
EP2058004A1 (en) * 2005-03-16 2009-05-13 University of Oxford Mannose immunogens for HIV-1
EP2932982B1 (en) * 2005-05-17 2018-10-03 Amicus Therapeutics, Inc. A method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives
WO2007014327A2 (en) * 2005-07-27 2007-02-01 University Of Florida Research Foundation, Inc. Small compounds that correct protein misfolding and uses thereof
NZ565954A (en) * 2005-07-27 2012-03-30 Univ Florida Use of heat shock inducing compound and an agent that increases stem cell mobilization int he manufacture of a medicament to treat ocular disease
US20070244184A1 (en) * 2006-01-09 2007-10-18 Simon Fraser University Glycosidase inhibitors and methods of synthesizing same
DE602007008870D1 (de) * 2006-04-24 2010-10-14 Amc Amsterdam Verbessertes verfahren zur behandlung von cystischer fibrose
EP2023927B1 (en) * 2006-05-24 2015-02-25 United Therapeutics Corporation Deoxynojirimycin and d-arabinitol analogs and methods of using
CN102727437A (zh) * 2006-08-02 2012-10-17 牛津大学院长校长专家委员会 病毒感染的脂质体治疗
CA2666814A1 (en) * 2006-08-21 2008-05-29 United Therapeutics Corporation Combination therapy for treatment of viral infections
CN101172127B (zh) * 2006-10-31 2011-12-07 上海市新文达生物科技有限公司 一种桑叶提取物及其在制备抗甲型流感病毒药物中的应用
CN102046151A (zh) * 2008-03-26 2011-05-04 牛津大学 靶向内质网的脂质体
CN101278977B (zh) * 2008-03-31 2012-05-30 广州唐百服生物科技有限公司 一种桑叶主要活性成分的提取方法及其提取物用途

Similar Documents

Publication Publication Date Title
JP2013503880A5 (enExample)
CN110325187B (zh) N-氨基甲酰亚胺基-5-(1-甲基-1h-吡唑-4-基)-2-萘甲酰胺在制备治疗流感的药物中的用途
JP2017531038A5 (enExample)
CN103269715B (zh) 用于改进流感病毒和疫苗种子的生产的方法
JP2009535352A5 (enExample)
JP2014500861A5 (enExample)
JP2013503881A5 (enExample)
JP2009501732A5 (enExample)
JP2014515351A5 (enExample)
JP2013537423A5 (enExample)
JP2009504763A5 (enExample)
WO2011000566A3 (en) Compounds and pharmaceutical compositions for the treatment of negative-sense ssrna virus infections
EA201201031A1 (ru) Ингибиторы вируса гепатита с
RU2011136250A (ru) Низкомолекулярное полисульфатированное производное гиалуроновой кислоты и содержащее его лекарственное средство
JP2012518649A5 (enExample)
WO2012018534A3 (en) Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
NZ598208A (en) Inhibitors of flaviviridae viruses
WO2008089125A2 (en) Antiviral compounds and methods of using thereof
JP2013503882A5 (enExample)
RU2016111704A (ru) Производные дезоксинойиримицина и способы их применения
JP2013542992A5 (enExample)
JP5653438B2 (ja) オルトミクソウイルス感染の治療方法
JP2017515840A5 (enExample)
JP2018506272A5 (enExample)
JP2015502973A5 (enExample)